Matt Huentelman

Matt Huentelman

UNVERIFIED PROFILE

Are you Matt Huentelman?   Register this Author

Register author
Matt Huentelman

Matt Huentelman

Publications by authors named "Matt Huentelman"

Are you Matt Huentelman?   Register this Author

18Publications

586Reads

21Profile Views

Common BACE2 Polymorphisms are Associated with Altered Risk for Alzheimer's Disease and CSF Amyloid Biomarkers in APOE ε4 Non-Carriers.

Sci Rep 2019 Jul 3;9(1):9640. Epub 2019 Jul 3.

Department of Psychiatry & Behavioral Sciences, Programs in Neuroscience and Human Genetics and Genomics and Center on Aging, Miller School of Medicine, University of Miami, Miami, FL, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41598-019-45896-4DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6610620PMC
July 2019

Precision Aging: Applying Precision Medicine to the Field of Cognitive Aging.

Front Aging Neurosci 2019 7;11:128. Epub 2019 Jun 7.

Department of Psychology, College of Science, University of Arizona, Tucson, AZ, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fnagi.2019.00128DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6568195PMC
June 2019

Genetic analysis suggests high misassignment rates in clinical Alzheimer's cases and controls.

Neurobiol Aging 2019 05 22;77:178-182. Epub 2019 Jan 22.

Department of Neurodegenerative Disorders, Institute of Neurology, Queen Square, London, UK. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.neurobiolaging.2018.12.002DOI Listing
May 2019

Recommendations of the Global Multiple System Atrophy Research Roadmap Meeting.

Neurology 2018 01 13;90(2):74-82. Epub 2017 Dec 13.

From Muhammad Ali Parkinson Center (R.R.W.), Barrow Neurological Institute, Phoenix, AZ; Department of Neurology (F.K., G.K.W., W.P., K.S., N.S.), Medical University Innsbruck, Austria; National Institute of Neurological Disorders and Stroke (W.R.G., W.J.K.), NIH, Bethesda, MD; Department of Neurology (P.A.L.), Mayo Clinic, Rochester, MN; Brain and Mind Centre (G.H.), Sydney Medical School, the University of Sydney; UNSW Medicine & Neuroscience Research Australia (G.H.), Sydney; Queen Square Brain Bank (J.H.), UCL Institute of Neurology (N.P.Q.), London, UK; UPS, INSERM, and CHU de Toulouse (O.R.), University de Toulouse; Centre de Référence Maladie Rare contre l'AMS (O.R.), Centre d'Investigation Clinique CIC1436, Départments de Pharmacologie Clinique et de Neurosciences, NeuroToul/COEN Center of Excellence in Neurodegeneration, Toulouse, France; Department of Pathology & Laboratory Medicine (L.M.S.), Perelman School of Medicine, University of Pennsylvania, Philadelphia; Center for Neurosciences (D.E.), The Feinstein Institute for Medical Research, Manhasset, NY; The Multiple System Atrophy (MSA) Coalition, Inc. (P. B., J.B., P.F., L.K., C.L., C.R., S.S.), Charlotte, NC; Cleveland Clinic Lou Ruvo Center for Brain Health (J.L.C.), Las Vegas, NV; Medical Affairs (V.A.), Teva Pharmaceuticals, Frazer, PA; Department of Neurology (G.B.), David Geffen School of Medicine, Brain Research Institute, and Molecular Biology Institute, University of California at Los Angeles; Institute of Neurology (D.J.B.), University of Newcastle upon Tyne, UK; Van Andel Research Institute (P. Brundin), Center for Neurodegenerative Science, Grand Rapids, MI; Center for Neurological Restoration (H.F.), Cleveland Clinic, OH; Defeat MSA (P.F.); MSA Shoe Charity (P.F., C.R.), Saint Clair Shores, MI; Department of Neurology (R.F.), Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA; Department of Neurodegenerative Diseases (T.G.), Hertie Institute of Clinical Brain Research, University of Tübingen; German Center for Neurodegenerative Diseases (DZNE) (T.G.), Tübingen, Germany; Lundbeck LLC (A.H.), Deerfield, IL; German Center for Neurodegenerative Diseases (DZNE) (G.U.H.), Munich; Department of Neurology (G.U.H.), Technical University of Munich, Germany; Neurogenomics Division (M.J.H.), The Translational Genomics Research Institute, Phoenix, AZ; Dandrite & Department of Biomedicine (P.H.J.), Aarhus University, Denmark; Quanterix (A.J.), Lexington, MA; Department of Neurology (U.J.K.), Columbia University Medical Center; Department of Neurology (H.K.), New York University School of Medicine, New York; Whitehead Institute for Biomedical Research (V.K.), Cambridge; Ann Romney Center for Neurologic Disease (V.K.), Department of Neurology, Brigham and Women's Hospital and Harvard Medical School, Boston; Harvard Stem Cell Institute (V.K.), Cambridge, MA; Department of Neurology (T.K.), University of Bonn; German Center for Neurodegenerative Diseases (DZNE) (T.K.), Bonn, Germany; Brain and Mind Centre (W.S.K.), Sydney Medical School, University of Sydney, Australia; Department of Neurology (P.L.), Henry Ford Hospital; Department of Neurology (P.L.), Wayne State University School of Medicine, Detroit, MI; Division of Neurosciences (E.M.), National Institute on Aging/NIH, Bethesda, MD; Centre de Référence Maladie Rare AMS (W.M.), Hôpital Pellegrin, CHU de Bordeaux; Université de Bordeaux (W.M.), Institut des Maladies Neurodégénératives, UMR 5293, Bordeaux; Paris Saclay Institute of Neuroscience (R.M.), CNRS, Gif-sur-Yvette, France; Genentech Inc. (S.O.), South San Francisco; Cedars-Sinai Medical Center (S.P.), Los Angeles, CA; Department of Neurology (D.R.), Vanderbilt University Medical Center, Nashville, TN; MSA NJ (C.R.), Howell, NJ; Prothena Biosciences (D.S.), South San Francisco, CA; Division of Neurology (M.S.), Department of Medicine, The Ottawa Hospital, Canada; Department of Neurology (J.D.S.), Massachusetts General Hospital, Harvard Medical School, Boston, MA; Cure MSA Foundation (L.S.), Fremont, CA; Avid Radiopharmaceuticals (A.S.), Philadelphia, PA; Department of Neurological Sciences (G.T.S.), Rush University Medical Center, Chicago, IL; Department of Neurology (S.T.), Graduate School of Medicine, Tokyo University, Tokyo, Japan; and University of Washington (J.Z.), Seattle. W.R.G. is currently affiliated with Janssen Research and Development, Titusville, NJ.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1212/WNL.0000000000004798DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5772155PMC
January 2018

Age-Modulated Associations between , Brain Volume, and Verbal Memory among Healthy Older Adults.

Front Aging Neurosci 2017 10;9:431. Epub 2018 Jan 10.

Cognition and Neuroimaging Laboratory, Department of Psychology, University of Arizona, Tucson, AZ, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fnagi.2017.00431DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5767716PMC
January 2018

Polygenic risk score analysis of pathologically confirmed Alzheimer disease.

Ann Neurol 2017 Aug 9;82(2):311-314. Epub 2017 Aug 9.

Department of Molecular Neuroscience and Reta Lilla Weston Laboratories, Institute of Neurology, London, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ana.24999DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5599118PMC
August 2017

MECP2 impairs neuronal structure by regulating KIBRA.

Neurobiol Dis 2016 07 22;91:284-91. Epub 2016 Mar 22.

Institute of Zoology- Neurobiology, Johannes Gutenberg University Mainz, 55128, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.nbd.2016.03.019DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5609186PMC
July 2016

Large-scale genomics unveil polygenic architecture of human cortical surface area.

Nat Commun 2015 Jul 20;6:7549. Epub 2015 Jul 20.

1] Multimodal Imaging Laboratory, Department of Radiology, University of California San Diego, La Jolla, California 92037, USA. [2] Department of Neurosciences, University of California, San Diego, La Jolla, California 92093, USA. [3] Department of Psychiatry, University of California, San Diego, La Jolla, California 92093, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/ncomms8549DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4518289PMC
July 2015

Angiotensin-converting enzyme 2 as a novel target for gene therapy for hypertension.

Exp Physiol 2005 May 7;90(3):299-305. Epub 2005 Jan 7.

Department of Pharmacodynamics, College of Pharmacy, University of Florida, PO Box 100487, Gainesville, FL 32610-0487, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1113/expphysiol.2004.028522DOI Listing
May 2005